Can Wegovy Cause a Rapid Heart Rate?

What the evidence actually shows about semaglutide and pulse rate

The STEP 1 trial, published in the New England Journal of Medicine, is the main source of data on semaglutide 2.4mg in adults with obesity. Heart rate was one of the cardiovascular parameters tracked. Participants on semaglutide did show a small average increase in resting heart rate compared with placebo, the kind of change measured in single digits of beats per minute rather than a dramatic acceleration.

That context matters. A jump from, say, 68 to 72 beats per minute on average is statistically present in the data but most people would not feel it. A rise from 68 to 92, felt as a pounding sensation, is a different story and should be taken seriously.

The NHS medicines information for semaglutide lists increased heart rate among the known side effects. It is not listed as common (meaning it does not affect most users), but it is documented and prescribers are aware of it. The mechanism is thought to relate to GLP-1 receptor activity having some direct cardiac effects, separate from the weight-loss action itself.

One misconception worth gently setting aside: if you are wondering whether Wegovy can cause a high heart rate, the answer is yes in some cases, but a faster pulse does not mean the medicine is damaging your heart. Semaglutide actually has a positive cardiovascular evidence base in people with established heart disease. The pulse change is a physiological response, not a sign that something is going wrong with cardiac tissue.

When a heart rate change is worth monitoring versus when to act

The practical question most people face is this: you have noticed your resting pulse is higher since starting Wegovy, and you are not sure whether to wait, call your GP, or stop the medicine. The honest answer depends on what the change feels like and what your baseline health picture is.

A mild increase that you only notice when you check a smartwatch, with no accompanying symptoms, is usually something to flag at your next prescriber review rather than an emergency. Many people find it settles as their body adjusts, particularly in the first few weeks on a new dose.

Symptoms that deserve prompt attention include: a racing or fluttering feeling in your chest at rest, palpitations that come on suddenly without exertion, a fast heart rate combined with shortness of breath or chest tightness, or light-headedness that you have not experienced before. These should not be self-managed. Call 111, contact your GP, or in an emergency call 999. If you are a patient and have a concern right now, you can also reach our aftercare team, who are available seven days a week.

People who already live with arrhythmias, have a pacemaker, or have had significant cardiac events in the past should make sure this is part of the conversation before they start. It is not a blanket reason to exclude Wegovy, but it is something a prescriber needs to weigh carefully.

How this fits into the wider picture of Wegovy and your health

Heart rate is one piece of a broader cardiovascular picture. It is worth knowing that Wegovy's evidence base includes a substantial cardiovascular outcomes trial showing reduced risk of major events such as heart attack and stroke in people with obesity and established cardiovascular disease. The medicine's overall effect on heart health, for eligible people, is considered positive by regulators and the clinical community.

The MHRA's Yellow Card scheme lets you report any suspected side effect, including heart-rate changes you want documented. It is a simple online form and contributes to ongoing safety monitoring for medicines like Wegovy.

If you are weighing up what Wegovy costs against what it might offer your health, our Wegovy cost page covers the private-prescription picture honestly. Cost is one factor; your cardiovascular history is another. Getting both into the same clinical conversation is what a proper consultation is designed for.

The decision about whether to continue, adjust, or review your treatment sits with your prescriber, who has access to your full history. If you are not yet on Wegovy and are wondering whether a pre-existing tendency toward a slightly fast resting pulse rules you out, the answer is: probably not, but it needs to be declared and assessed. Every person's situation is different.

What to tell your prescriber about heart rate symptoms

If you are a current or prospective Wegovy patient and heart rate is on your mind, the most useful thing you can do is document what you are experiencing. A pulse reading taken at the same time each morning, before getting up, gives your prescriber something concrete to work with rather than a vague feeling that things seem faster.

Information worth sharing: your resting rate before starting, your current readings, whether the change came on after a dose increase, whether it comes with any other symptoms, and any relevant cardiac history you have. Our clinical team reviews this kind of information carefully before approving treatment or dose changes. No detail is too small when it concerns cardiovascular symptoms.

For a broader picture of how Wegovy can affect your heart rate, including other side effects and how the medicine works, the Wegovy and heart rate overview covers the full topic. If you want to explore treatment options and speak to a prescriber directly, you can start a free consultation through our prescribers, who are available to review your situation the same day.